High rate of febrile neutropenia in patients with operable breast cancer receiving docetaxel and cyclophosphamide.
Soong
Derrick
D
Haj
Reem
R
Leung
Mova G
MG
Myers
Robert
R
Higgins
Brian
B
Myers
Jeff
J
Rajagopal
Sudha
S
D019072:Antibiotic Prophylaxis; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy*; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects; D000077143:Docetaxel; D005334:Fever / Q000139:chemically induced* / Q000517:prevention & control; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use; D006801:Humans; D009503:Neutropenia / Q000139:chemically induced* / Q000517:prevention & control; D043823:Taxoids / Q000008:administration & dosage / Q000009:adverse effects
D043823:Taxoids; D016179:Granulocyte Colony-Stimulating Factor; D000077143:Docetaxel; D003520:Cyclophosphamide